![Michael M. Kitt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael M. Kitt
Chief Executive Officer at
Axalbion Therapeutics Ltd.
Profile
Michael M.
Kitt currently works at Axalbion Therapeutics Ltd., as Chief Executive Officer & Director.
Dr. Kitt also formerly worked at Attenua, Inc., as President, CEO, CFO & Director from 2018 to 2019, COR Therapeutics, Inc., as Vice President-Clinical Research from 1993 to 2002, The Upjohn Co., as Vice President-International Clinical Research, Portola Pharmaceuticals LLC, as Chief Medical Officer & Senior Vice President from 2011 to 2013, Afferent Pharmaceuticals, Inc., as Chief Medical Officer, Innoviva, Inc., as Senior Vice President-Development from 2002 to 2008, Nuon Therapeutics, Inc., as Chief Medical Officer from 2008 to 2011, and Sterling Winthrop Pharmaceuticals Research Center, as Senior Vice President-Clinical Research.
Dr. Kitt received his undergraduate degree from New York University Tandon School of Engineering and doctorate degree from New York University School of Medicine.
Michael M. Kitt active positions
| Companies | Position | Start |
|---|---|---|
Axalbion Therapeutics Ltd.
 Axalbion Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company that developing TRPM8 agonists for the treatment of chronic cough and dry eyes | Chief Executive Officer | 2019-10-31 |
Former positions of Michael M. Kitt
| Companies | Position | End |
|---|---|---|
Attenua, Inc.
 Attenua, Inc. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical services | Chief Executive Officer | 2019-10-31 |
| PORTOLA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2013-08-15 |
Nuon Therapeutics, Inc.
 Nuon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat inflammation and neurological diseases | Chief Tech/Sci/R&D Officer | 2011-05-31 |
The Upjohn Co.
 The Upjohn Co. Pharmaceuticals: MajorHealth Technology Manufacturer of pharmaceuticals | Chief Tech/Sci/R&D Officer | 2011-02-24 |
| INNOVIVA, INC. | Corporate Officer/Principal | 2008-06-19 |
Training of Michael M. Kitt
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
61
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
COR Therapeutics, Inc.
 COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops biopharmaceutical products for acute cardiovascular diseases | Health Technology |
The Upjohn Co.
The Upjohn Co. Pharmaceuticals: MajorHealth Technology Manufacturer of pharmaceuticals | Health Technology |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapeutics | Health Technology |
Afferent Pharmaceuticals, Inc.
 Afferent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, selective drugs for the treatment of a range of debilitating neurogenic disorders | Health Technology |
Innoviva, Inc.
 Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs | Health Technology |
Nuon Therapeutics, Inc.
Nuon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat inflammation and neurological diseases | Health Technology |
Sterling Winthrop Pharmaceuticals Research Center | |
New York University Tandon School of Engineering
 New York University Tandon School of Engineering Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University School of Medicine
 New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Attenua, Inc.
Attenua, Inc. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical services | Health Technology |
Axalbion Therapeutics Ltd.
Axalbion Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company that developing TRPM8 agonists for the treatment of chronic cough and dry eyes | Health Technology |
- Stock Market
- Insiders
- Michael M. Kitt
